What is William Blair’s Estimate for XENE Q1 Earnings?
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Xenon Pharmaceuticals in a note issued to investors on Monday, March 17th. William Blair analyst M. Minter anticipates that the biopharmaceutical company will post earnings per share of ($1.01) […]
